X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cholesterol (3) 3
cardiovascular (2) 2
niacin (2) 2
nicotinic-acid (2) 2
primary hypercholesterolemia (2) 2
safety (2) 2
abridged index medicus (1) 1
adolescent (1) 1
adult (1) 1
aged (1) 1
atherosclerosis (1) 1
bile acids (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular disease (1) 1
clinical trials (1) 1
coadministration (1) 1
double-blind method (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
dyslipidemia (1) 1
dyslipidemias - drug therapy (1) 1
extended-release niacin (1) 1
ezetimibe (1) 1
female (1) 1
flushing (1) 1
flushing - chemically induced (1) 1
flushing - drug therapy (1) 1
humans (1) 1
hypercholesterolemia (1) 1
hypolipidemic agents - adverse effects (1) 1
hypolipidemic agents - therapeutic use (1) 1
index medicus (1) 1
indoles - adverse effects (1) 1
indoles - therapeutic use (1) 1
laropiprant (1) 1
lipids (1) 1
low density lipoproteins (1) 1
low-density lipoprotein cholesterol (1) 1
male (1) 1
medical and health sciences (1) 1
medicin (1) 1
medicin och hälsovetenskap (1) 1
medicine (1) 1
middle aged (1) 1
mixed hyperlipidemia (1) 1
niacin - adverse effects (1) 1
niacin - therapeutic use (1) 1
pharmacology & pharmacy (1) 1
prevention (1) 1
safety and security measures (1) 1
simvastatin (1) 1
tolerability (1) 1
treatment outcome (1) 1
universities and colleges (1) 1
young adult (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2009, Volume 3, Issue 3, pp. 179 - 186
Background Niacin has proven lipid-modifying efficacy and cardiovascular benefit; however, it is underused because of skin flushing, a process mediated... 
Cardiovascular | Mixed hyperlipidemia | Flushing | Laropiprant | Extended-release niacin | Primary hypercholesterolemia | NICOTINIC-ACID | CHOLESTEROL | SAFETY | TOLERABILITY | PREVENTION | PHARMACOLOGY & PHARMACY | NIACIN
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2005, Volume 27, Issue 2, pp. 174 - 184
Ezetimibe (EZE) is a cholesterol-loweringdrug that inhibits absorption of dietary and biliary cholesterol across the intestinal wall without affecting... 
simvastatin | ezetimibe | low-density lipoprotein cholesterol | safety | hypercholesterolemia | coadministration | Lipids | Bile acids | Drug therapy, Combination | Simvastatin | Low density lipoproteins | Cholesterol
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.